Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prognostic Factors
100%
Hepatosplenic T-cell Lymphoma
100%
Feature Factor
100%
Neoplasms
16%
Liver
16%
Differential Diagnosis
16%
Standard of Care
16%
Bone Marrow
16%
Gene mutation
16%
Targets for Therapy
16%
Multi-institutional
16%
Lymphadenopathy
16%
Acute Leukemia
16%
T Cell Receptor
16%
Cytopenia
16%
T-cell Lymphoma
16%
Clinical Trials
16%
ARID1A
16%
CD-8
16%
Therapeutic Approaches
16%
Lymphoma Patients
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Spleen
16%
Lymphoma Cells
16%
Older Adults
16%
T Cell Lineage
16%
Cell Size
16%
Study Support
16%
B Symptoms
16%
JAK-STAT Pathway
16%
Identified Genes
16%
Chromatin Modification
16%
Oncogenic Pathways
16%
Extranodal Disease
16%
Genetic Characteristics
16%
Consensus Standards
16%
Diagnosis Approach
16%
SETD2
16%
Institutional Approach
16%
Medicine and Dentistry
Prognostic Factor
100%
Hepatosplenic T-Cell Lymphoma
100%
Pathogenesis
100%
Gene Mutation
16%
Carcinogenesis
16%
Diseases
16%
Neoplasm
16%
Differential Diagnosis
16%
Clinical Trial
16%
T Cell
16%
Acute Leukemia
16%
Lymphoma Cell
16%
Lymphadenopathy
16%
Hematopoietic Stem Cell Transplantation
16%
T-Cell Lymphoma
16%
Cytopenia
16%
Adolescence
16%
CD8 Antigen
16%
B Symptoms
16%
Chromatin
16%
Cell Lineage
16%
T Lymphocyte Receptor
16%
Cell Size
16%
JAK-STAT Signaling
16%
Genetic Trait
16%